# Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure

> **NCT06653725** · PHASE2 · RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Acute Heart Failure (AHF)

## Interventions

- **DIETARY_SUPPLEMENT:** 1,3-butanediol
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06653725
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-20
- **Primary completion:** 2027-11-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06653725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06653725, "Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06653725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*